Allurion Technologies (ALUR) Stock Overview
Focuses on developing a weight loss platform for overweight people in Spain, France, Turkey, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 2/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
ALUR Community Fair Values
Create NarrativeSee what 12 others think this stock is worth. Follow their fair value or set your own to get alerts.
Analyst Price Targets
Allurion Technologies Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.80 |
| 52 Week High | US$3.42 |
| 52 Week Low | US$0.23 |
| Beta | -0.21 |
| 1 Month Change | -3.67% |
| 3 Month Change | -27.28% |
| 1 Year Change | -66.11% |
| 3 Year Change | -99.57% |
| 5 Year Change | -99.53% |
| Change since IPO | -99.54% |
Recent News & Updates
Recent updates
ALUR: Expanded Brazil Hospital Network Will Drive Obesity Therapy Access
Narrative Update on Allurion Technologies: Analyst Price Target Revision Analysts have raised their price target for Allurion Technologies from $5.83 to $7.00. They cite improved revenue growth projections and a slight uplift in expected profit margin as the primary factors behind the upward revision.Expanding Obesity Solutions Will Boost Prospects Amid Launch Uncertainties
A significant reduction in consensus revenue growth forecasts has driven the analyst price target for Allurion Technologies down from $8.38 to $5.83. What's in the News Allurion Technologies was unable to file its next 10-Q by the required SEC deadline.Expanding Obesity Solutions Will Boost Prospects Amid Launch Uncertainties
With consensus forecasts for both revenue growth and net profit margin remaining steady, analysts have left their fair value estimate for Allurion Technologies unchanged at $8.38. What's in the News Allurion Technologies announced a strategic Canadian distribution partnership with Minogue Medical Inc., leveraging Minogue's national network of obesity care providers to expand access to Allurion's metabolically healthy weight loss program.
Low-dose GLP-1 Combo And FDA Approval Will Expand Obesity Care
The combination therapy approach and clinical advancements are set to drive increased revenue and expand market share in obesity and related treatments.Take Care Before Jumping Onto Allurion Technologies Inc. (NYSE:ALUR) Even Though It's 42% Cheaper
Allurion Technologies Inc. ( NYSE:ALUR ) shareholders that were waiting for something to happen have been dealt a blow...Shareholder Returns
| ALUR | US Consumer Services | US Market | |
|---|---|---|---|
| 7D | 16.3% | -0.7% | 2.6% |
| 1Y | -66.1% | -22.8% | 26.2% |
Return vs Industry: ALUR underperformed the US Consumer Services industry which returned -22.8% over the past year.
Return vs Market: ALUR underperformed the US Market which returned 26.2% over the past year.
Price Volatility
| ALUR volatility | |
|---|---|
| ALUR Average Weekly Movement | 40.4% |
| Consumer Services Industry Average Movement | 7.7% |
| Market Average Movement | 7.2% |
| 10% most volatile stocks in US Market | 16.1% |
| 10% least volatile stocks in US Market | 3.2% |
Stable Share Price: ALUR's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: ALUR's weekly volatility has increased from 23% to 40% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | 40 | Shantanu Gaur | www.allurion.com |
Allurion Technologies Inc. focuses on developing a weight loss platform for overweight people in Spain, France, Turkey, and internationally. Its Allurion Program platform offers the Allurion Smart Capsule, a swallowable and procedure-less intragastric balloon for weight loss, and access to the Allurion Virtual Care Suite, a digital therapeutic that combines AI-powered remote patient monitoring tools with a behavior change program. The company is headquartered in Natick, Massachusetts.
Allurion Technologies Inc. Fundamentals Summary
| ALUR fundamental statistics | |
|---|---|
| Market cap | US$10.65m |
| Earnings (TTM) | -US$28.75m |
| Revenue (TTM) | US$15.23m |
Is ALUR overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| ALUR income statement (TTM) | |
|---|---|
| Revenue | US$15.23m |
| Cost of Revenue | US$5.66m |
| Gross Profit | US$9.57m |
| Other Expenses | US$38.33m |
| Earnings | -US$28.75m |
Last Reported Earnings
Dec 31, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | -1.92 |
| Gross Margin | 62.84% |
| Net Profit Margin | -188.81% |
| Debt/Equity Ratio | -98.2% |
How did ALUR perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/05/12 22:05 |
| End of Day Share Price | 2026/05/12 00:00 |
| Earnings | 2025/12/31 |
| Annual Earnings | 2025/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Allurion Technologies Inc. is covered by 4 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Keay Nakae | Chardan Capital Markets, LLC |
| Michael Toomey | Jefferies LLC |
| Matthew Taylor | Jefferies LLC |